Facilitated production of secretory IgA against Shiga toxin B subunits by intranasal application of antigen-coated polystyrene microspheres

Microbiology and Immunology

Volumn 49, Issue 2, 2005, Pages 149-154

  Kurohane, Kohta ^a   Kobayashi, Chie ^a   Imai, Yasuyuki ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Mucosal immunity; O157:H7; Shiga toxin

Indexed keywords

ANTIGEN; CHOLERA TOXIN; DRUG CARRIER; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; MICROSPHERE; OVALBUMIN; POLYSTYRENE; SECRETORY IMMUNOGLOBULIN; SHIGA TOXIN; SHIGA TOXIN B SUBUNIT; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 14944347932     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2005.tb03714.x     Document Type: Article

References (36)

1. Aramaki, Y., Fujii, Y., Yachi, K., Kikuchi, H., and Tsuchiya, S. 1994. Activation of systemic and mucosal immune response following nasal administration of liposomes. Vaccine 12: 1241-1245.
2. Baca-Estrada, M.E., Foldvari, M.M., Snider, M.M., Harding, K.K., Kournikakis, B.B., Babiuk, L.A., and Griebel, P.P. 2000. Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses. Vaccine 18: 2203-2211.
3. Bast, D.J., Sandhu, J., Hozumi, N., Barber, B., and Brunton, J. 1997. Murine antibody responses to the verotoxin 1 B subunit: demonstration of major histocompatibility complex dependence and an immunodominant epitope involving phenylalanine 30. Infect. Immun. 65: 2978-2982.
4. Brandtzaeg, P. 2003. Role of secretory antibodies in the defence against infections. Int. J. Med. Microbiol. 293: 3-15.
5. Calderwood, S.B., Auclair, F., Donahue-Rolfe, A., Keusch, G.T., and Mekalanos, J.J. 1987. Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 84: 4364-4368.
6. de Lorimier, A.J., Byrd, W., Hall, E.R., Vaughan, W.M., Tang, D., Roberts, Z.J., McQueen, C.E., and Cassels, F.J. 2003. Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6. Vaccine 21: 2548-2555.
7. Debin, A., Kravtzoff, R., Santiago, J.V., Cazales, L., Sperandio, S., Melber, K., Janowicz, Z., Betbeder, D., and Moynier, M. 2002. Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses. Vaccine 20: 2752-2763.
8. Ermak, T.H., and Giannasca, P.J. 1998. Microparticle targeting to M cells. Adv. Drug Delivery Rev. 34: 261-283.
9. Foster, N., Clark, M.A., Jepson, M.A., and Hirst, B.H. 1998. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine 16: 536-541.
10. Freytag, L.C., and Clements, J.D. 1999. Bacterial toxins as mucosal adjuvants. Curr. Top. Microbiol. Immunol. 236: 215-236.
11. Giannasca, P.J., Boden, J.A., and Monath, T.P. 1997. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect. Immun. 65: 4288-4298.
12. Goetsch, L., Gonzalez, A., Plotnicky-Gilquin, H., Haeuw, J.F., Aubry, J.P., Beck, A., Bonnefoy, J.Y., and Corvaia, N. 2001. Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae. Infect. Immun. 69: 6434-6444.
13. Harokopakis, E., Hajishengallis, G., and Michalek, S.M. 1998. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system. Infect. Immun. 66: 4299-4304.
14. Hodge, L.M., Marinaro, M., Jones, H.P., McGhee, J.R., Kiyono, H., and Simecka, J.W. 2001. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization. Infect. Immun. 69: 2328-2338.
15. Imai, Y., Matsuura, Y., Ono, Y., Ishikawa, T., and Ito, Y. 2001. Demonstration of the pH sensitive binding of multi-valent carbohydrate ligands to immobilized Shiga-like toxin 1 B subunits. J. Biochem. (Tokyo) 130: 665-670.
16. Imai, Y., Nagai, R., Ono, Y., Ishikawa, T., Nakagami, H., Tanikawa, T., and Kurohane, K. 2004. Production of secretory immunoglobulin A against Shiga toxin-binding subunits in mice by mucosal immunization. Infect. Immun. 72: 889-895.
17. Jackson, M.P., Neill, R.J., O'Brien, A.D., Holmes, R.K., and Newland, J.W. 1987. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol. Lett. 44: 109-114.
18. Kraehenbuhl, J.P., and Neutra, M.R. 2000. Epithelial M cells: differentiation and function. Annu. Rev. Cell Dev. Biol. 16: 301-332.
19. Lingwood, C.A. 1996. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4: 147-153.
20. Maloy, K.J., Donachie, A.M., O'Hagan, D.T., and Mowat, A.M. 1994. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology 81: 661-667.
21. Marcotte, H., and Lavoie, M.C. 1998. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol. Mol. Biol. Rev. 62: 71-109.
22. Matsunaga, Y., Wakatsuki, Y., Tabata, Y., Kawasaki, H., Usui, T., Yoshida, M., Itoh, T., Habu, S., and Kita, T. 2000. Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization. Vaccine 19: 579-588.
23. McDermott, M.R., and Bienenstock, J. 1979. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122: 1892-1898.
24. McDermott, M.R., Heritage, P.L., Bartzoka, V., and Brook, M.A. 1998. Polymer-grafted starch microparticles for oral and nasal immunization. Immunol. Cell Biol. 76: 256-262.
25. Miyashita, S., Matsuura, Y., Miyamoto, D., Suzuki, Y., and Imai, Y. 1999. Development of recombinant B subunit of Shiga-like toxin 1 as a probe to detect carbohydrate ligands in immunochemical and flowcytometric application. Glycoconjugate J. 16: 697-705.
26. Nataro, J.P., and Kaper, J.B. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201.
27. Neutra, M.R. 1998. Current concepts in mucosal immunity. V. Role of M cells in transepithelial transport of antigens and pathogens to the mucosal immune system. Am. J. Physiol. 274: G785-791.
28. Phalipon, A., Cardona, A., Kraehenbuhl, J.-P., Edelman, L., Sansonetti, P.J., and Corthésy, B. 2002. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 17: 107-115.
29. Sakaue, G., Hiroi, T., Nakagawa, Y., Someya, K., Iwatani, K., Sawa, Y., Takahashi, H., Honda, M., Kunisawa, J., and Kiyono, H. 2003. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. J. Immunol. 170: 495-502.
30. Shikina, T., Hiroi, T., Iwatani, K., Jang, M.H., Fukuyama, S., Tamura, M., Kubo, T., Ishikawa, H., and Kiyono, H. 2004. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. J. Immunol. 172: 6259-6264.
31. Tabata, Y., Inoue, Y., and Ikada, Y. 1996. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine 14: 1677-1685.
32. Takao, T., Tanabe, T., Hong, Y.-M., Shimonishi, Y., Kurazono, H., Yutsudo, T., Sasakawa, C., Yoshikawa, M., and Takeda, Y. 1988. Identity of molecular structure of Shiga-like toxin I (VT1) from Escherichia coli O157:H7 with that of Shiga toxin. Microb. Pathog. 5: 357-369.
33. Williams, N.A., Hirst, T.R., and Nashar, T.O. 1999. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol. Today 20: 95-101.
34. Wu, H.Y., Abdu, S., Stinson, D., and Russell, M.W. 2000. Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect. Immun. 68: 5539-5545.
35. Wu, H.Y., and Russell, M.W. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61: 314-322.
36. Zuercher, A.W., Jiang, H.Q., Thurnheer, M.C., Cuff, C.F., and Cebra, J.J. 2002. Distinct mechanisms for cross-protection of the upper versus lower respiratory tract through intestinal priming. J. Immunol. 169: 3920-3925.